Open AccessS806 Mirikizumab-Induced Transcriptome Changes in Patient Biopsies at Week 12 Are Maintained Through Week 52 in Patients With Ulcerative Colitis
Author(s) -
Travis Johnson,
Boyd Steere,
Pengyue Zhang,
Yong Zang,
Richard E. Higgs,
Klaus Gottlieb,
Walter Reinisch,
Julián Panés,
Venkatesh Krishnan
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776756.39821.45
Subject(s) - medicine , ulcerative colitis , placebo , gastroenterology , transcriptome , gene expression , gene , disease , pathology , biology , biochemistry , alternative medicine